Table 5 Weighted cox regression analysis for variables affecting event-free time
From: Mutational status predicts the risk of thromboembolic events in lung adenocarcinoma
Variable | HR (95% CI) |
|---|---|
Gender | |
Male | 1 |
Female | 0.88 (0.50–1.55) |
Age | |
< 66 | 1 |
> 66 | 0.37 (0.20–0.70) |
Stadium | |
I | 1 |
II | 2.64 (0.73–9.57) |
III | 2.40 (0.70–8.24) |
IV | 3.63 (1.05–12.50) |
AC before the target event | |
NO | 1 |
YES | 1,03 (0.45–2.33) |
Treatment options | |
CTP alone | 1 |
Other treatment without TKI | 0.20 (0.08–0.51) |
Other treatment with TKI | 0.25 (0.12–0.51) |
TKI alone | 0.14 (0.05–0.43) |